Access Resources
1651 - 1675 of 7611 Results
Title
Year
-
RESTRICTEDTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 6
-
RESTRICTEDTitle: A Modified Progressive Supranuclear Palsy Rating Scale for Virtual AssessmentsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1265End Page: 1271Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28991Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232989Citation Count: 9
-
RESTRICTEDTitle: A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 57End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.021Citation Count: 9
- Anxiety predicts impulsive-compulsive behaviours in Parkinson's disease: Clinical relevance and theoretical implications2022RESTRICTEDTitle: Anxiety predicts impulsive-compulsive behaviours in Parkinson's disease: Clinical relevance and theoretical implicationsJournal Name: Journal of Psychiatric ResearchPublisher: Elsevier BVVol: 148Issue #:Start Page: 220End Page: 229Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychires.2022.01.052Citation Count: 2
- Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population2022RESTRICTEDTitle: Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 4Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0003Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2789505/jamaneurology_simonet_2022_oi_220001_1649435706.38428.pdfCitation Count: 25
-
RESTRICTEDTitle: Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brainJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 177Issue #:Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2021.12.004Citation Count: 1
-
RESTRICTEDTitle: Brain health: The hidden casualty of a humanitarian crisisJournal Name: The Lancet Regional Health - EuropePublisher: Elsevier BVVol: 15Issue #:Start Page: 100374End Page: 100374Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.lanepe.2022.100374Best OA location URL: https://doi.org/10.1016/j.lanepe.2022.100374Citation Count: 4
-
RESTRICTEDTitle: Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 4Start Page: 381End Page: 392Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00377-xBest OA location URL: https://europepmc.org/articles/pmc8985079?pdf=renderCitation Count: 72
- Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study2022RESTRICTEDTitle: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 115Issue #:Start Page: 106713End Page: 106713Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2022.106713Best OA location URL: https://doi.org/10.1016/j.cct.2022.106713Citation Count: 6
- Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial2022RESTRICTEDTitle: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD TrialJournal Name: Genomics, Proteomics & BioinformaticsPublisher: Oxford University Press (OUP)Vol: 20Issue #: 2Start Page: 274End Page: 287Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009Best OA location URL: https://doi.org/10.1016/j.gpb.2021.08.009Citation Count: 26
-
RESTRICTEDTitle: Functional tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120208End Page: 120208Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jns.2022.120208Best OA location URL: http://www.jns-journal.com/article/S0022510X22000703/pdfCitation Count: 8
- Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology2022RESTRICTEDTitle: Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technologyJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120197End Page: 120197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120197Best OA location URL: http://www.jns-journal.com/article/S0022510X22000594/pdfCitation Count: 10
-
RESTRICTEDTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 3
- La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles2022RESTRICTEDTitle: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnellesJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152Citation Count: 0
-
RESTRICTEDTitle: Levodopa-induced dyskinesia: a brief review of the ongoing clinical trialsJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 2Start Page: 51End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0051Citation Count: 3
-
RESTRICTEDTitle: Mechanisms underlying ubiquitin-driven selective mitochondrial and bacterial autophagyJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 1501End Page: 1513Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2022.03.012Best OA location URL: http://www.cell.com/article/S1097276522002210/pdfCitation Count: 44
- Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine2022RESTRICTEDTitle: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 47End Page: 51Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017Best OA location URL: http://www.prd-journal.com/article/S1353802022000505/pdfCitation Count: 3
- Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells2022RESTRICTEDTitle: Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cellsJournal Name: FEBS Open BioPublisher: WileyVol: 12Issue #: 5Start Page: 959End Page: 982Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/2211-5463.13398Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063438Citation Count: 2
-
RESTRICTEDTitle: Multi-modality machine learning predicting Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00288-wBest OA location URL: https://www.nature.com/articles/s41531-022-00288-w.pdfCitation Count: 41
-
RESTRICTEDTitle: New insights into the genetic etiology of Alzheimer’s disease and related dementiasJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 54Issue #: 4Start Page: 412End Page: 436Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41588-022-01024-zBest OA location URL: https://www.nature.com/articles/s41588-022-01024-z.pdfCitation Count: 770
- Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease2022RESTRICTEDTitle: Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's diseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 2Start Page: 77End Page: 91Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0057Best OA location URL: https://doi.org/10.2217/nmt-2021-0057Citation Count: 4
-
RESTRICTEDTitle: Smoking is associated with age at disease onset in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 79End Page: 83Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.03.005Best OA location URL: http://manuscript.elsevier.com/S1353802022000633/pdf/S1353802022000633.pdfCitation Count: 2
-
RESTRICTEDTitle: Spastic Paraplegia Type 7 and Movement Disorders: Beyond the Spastic ParaplegiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 4Start Page: 522End Page: 529Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13437Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13437Citation Count: 6
- Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype2022RESTRICTEDTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 9
-
RESTRICTEDTitle: The clinical and electrophysiological investigation of tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 136Issue #:Start Page: 93End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.clinph.2022.01.004Best OA location URL: https://doi.org/10.1016/j.clinph.2022.01.004Citation Count: 19